Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 5/20 | 0.46 |
| ▸ | PIM3 | Q86V86 | 5/20 | 0.46 |
| ▸ | PIM2 | Q9P1W9 | 5/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4997591 | 0.90 | CYP11B1 (0.47) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4992191 | 0.86 | MAPT (0.54) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4994571 | 0.85 | SMN1; SMN2 (0.51) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4997577 | 0.85 | CYP11B2 (0.53) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4992184 | 0.84 | MAPT (0.52) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4996961 | 0.83 | MEN1 (0.51) | LMNAMAPTCYP11B1CYP11B2PIM1 | |
| SCHEMBL4997488 | 0.83 | LMNA (0.50) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4997627 | 0.82 | NPC1 (0.55) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4993263 | 0.82 | MAPT (0.47) | LMNASMN1; SMN2MAPTNFKB1NFKB2 | |
| SCHEMBL4996249 | 0.82 | MAPT (0.50) | LMNASMN1; SMN2MAPTNFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080194574-A1 | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases | AXXIMA PHARMACEUTICALS AG (DE) | 2008-08-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194574-A1 | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases | PRNP, PSEN1, PPP5C | LMNA 2743/4885SMN1; SMN2 896/4885MAPT 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.